Straits Times Index
3,332.80 -10.55 (-0.32%) Nikkei
39,583.08 +241.54 (+0.61%) Hang Seng
17,718.61 +2.14 (+0.01%) FTSE 100
8,164.12 -15.56 (-0.19%) Bitcoin USD
60,131.14 -1,334.22 (-2.17%) CMC Crypto 200
1,257.83 -26.00 (-2.03%)
RGNX Jul 2024 22.500 put
| Previous close | 6.50 |
| Open | 6.50 |
| Bid | 2.30 |
| Ask | 4.20 |
| Strike | 22.50 |
| Expiry date | 2024-07-19 |
| Day's range | 6.50 - 6.50 |
| Contract range | N/A |
| Volume | |
| Open interest | 2 |
Insider MonkeyWhy Did Analysts Maintain a Bullish Stance on REGENXBIO Inc. (RGNX) Despite Decline In Its Revenue Growth?
We recently compiled a list of the Top 10 Small-Cap Stocks with Highest Upside Potential. In this article, we are going to take a look at where REGENXBIO Inc. (NASDAQ:RGNX) stands against the other small-cap stocks. Small-cap stocks are companies with a market capitalization of somewhere between $250 million and $2 billion. They are usually the […]
ZacksRegenxbio (RGNX) Soars 6.4%: Is Further Upside Left in the Stock?
Regenxbio (RGNX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
PR NewswireREGENXBIO Announces Expansion of AFFINITY DUCHENNE® Trial to Include a New Cohort of Younger Patients
REGENXBIO Inc. (Nasdaq: RGNX) today announced it initiated enrollment in a new cohort of patients ages 1-3 in its Phase I/II AFFINITY DUCHENNE® trial to evaluate the safety and efficacy of RGX-202 in boys with Duchenne muscular dystrophy (Duchenne).
